Evaluation of Metacognitive Training for Depression (D-MKT) in psychosomatic rehabilitation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00007907

Enrollment

Registered

2015-04-30

Start date

2012-04-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F34 F33

Interventions

Group 1: Metacognitive Training for Depression (D-MCT), 8 sessions (60min)

twice a week over a period of 4 weeks. Metacognitive Training for depression (D-MCT) is a low-threshold, easy to administer group intervention. It aims at the reduction of depressive symptoms by chan

not only biases targeted in cognitive behavioral therapy but also those identified by basic research. Group 2: Health Training Group (Walking/ Psychoeducation on health)

8 sessions (60min), twice a week over a period of 4 weeks

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: a diagnosis of major depression or dysthymia

Exclusion criteria

Exclusion criteria: Patients were excluded if they were younger than 18 or older than 65 years, suffered from psychotic symptoms (i.e., hallucinations, delusions, or bipolar disorder), or were currently suicidal (SBQ-R = 7).

Design outcomes

Primary

Measure	Time frame
Primary outcome is change on the Hamilton Depression Rating Scale (HDRS, 17-item version) from baseline to follow-up (t0-t2).	—

Secondary

Measure	Time frame
Secondary outcome measures are self-assessed depression as measured by the well-established and widely-used Beck-Depression Inventory (BDI, Beck, 1995) as well as cognitive biases, self-esteem, quality of life and a memory paradigm. These are assessed in patients by the use of the following instruments at baseline, after 4 weeks of treatment and at follow up (6 months after treatment): Beck-Depression Inventory (BDI), Dysfunctional Attitude Scale (DAS), Metacognitons Questionnaire (MCQ-30), Rosenberg Self-Esteem Scale (RSE), World Health Organization Quality of Life Assessment (WHOQOL-BREF), Trail-Making Test (TMT), false memory paradigm (only baseline and post assessment)	—

Measure

Time frame

Secondary outcome measures are self-assessed depression as measured by the well-established and widely-used Beck-Depression Inventory (BDI, Beck, 1995) as well as cognitive biases, self-esteem, quality of life and a memory paradigm. These are assessed in patients by the use of the following instruments at baseline, after 4 weeks of treatment and at follow up (6 months after treatment): Beck-Depression Inventory (BDI), Dysfunctional Attitude Scale (DAS), Metacognitons Questionnaire (MCQ-30), Rosenberg Self-Esteem Scale (RSE), World Health Organization Quality of Life Assessment (WHOQOL-BREF), Trail-Making Test (TMT), false memory paradigm (only baseline and post assessment)

—

Countries

Germany

Contacts

Public ContactLena Jelinek

Universitätsklinikum Hamburg-Eppendorf Klinik für Psychiatrie und Psychotherapie

ljelinek@uke.uni-hamburg.de+49 40 741055868

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 24, 2026